UroGen Pharma Ltd. (URGN) vs U.S. Physical Therapy, Inc. (USPH)
UroGen Pharma Ltd. and U.S. Physical Therapy, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — URGN vs USPH, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| UroGen Pharma Ltd. (URGN) | U.S. Physical Therapy, Inc. (USPH) | |
|---|---|---|
| Market cap | $1.4B | $0.9B |
| Revenue (latest FY) | $109.79M | $780.99M |
| Net income (latest FY) | $-153.49M | $39.58M |
| Revenue growth (5y CAGR) | 56.2% | 13.0% |
| Net margin | -139.8% | 5.1% |
| Return on equity | 145.5% | 8.3% |
| P/E ratio | — | 124.5 |
| Dividend yield | — | 2.9% |
| Profitable years (of last 10) | 0 | 10 |
| Positive free cash flow | No | Yes |
Performance — URGN vs USPH
Total returns from monthly split- and dividend-adjusted closes; 52-week range from the latest quote. Past performance is not a prediction.
| UroGen Pharma Ltd. (URGN) | U.S. Physical Therapy, Inc. (USPH) | |
|---|---|---|
| 1-year return | 106.6% | -18.4% |
| 3-year return | 173.5% | -45.3% |
| 5-year return | 85.4% | -40.8% |
| 10-year return | — | 19.4% |
| 52-week range | $6.92–$32.37 | $58.19–$93.50 |
Verify the comparison
Use the filing period and source shown by each tool before treating two figures as comparable.
See the full URGN vs USPH breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open URGN's full financials → Open USPH's full financials →More comparisons
Frequently asked questions
Which is bigger, URGN or USPH?
UroGen Pharma Ltd. is larger by market capitalization — $1.4B versus $0.9B.
Which grows faster, URGN or USPH?
Over the last five fiscal years, UroGen Pharma Ltd. grew revenue faster — 56.2%/yr versus 13.0%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.